Title : Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.

Pub. Date : 2001 Jan

PMID : 11145597






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 By analyzing the cAMP response, the rank order of response observed was PACAP 38 > PACAP 27 > helodermin > VIP > helospectin > glucagon > PHI >>> secretin. Cyclic AMP adenylate cyclase activating polypeptide 1 Mus musculus
2 By analyzing the cAMP response, the rank order of response observed was PACAP 38 > PACAP 27 > helodermin > VIP > helospectin > glucagon > PHI >>> secretin. Cyclic AMP adenylate cyclase activating polypeptide 1 Mus musculus
3 The VIP-2R/PACAP-R antagonist, PACAP 6-38, inhibited both VIP- and PACAP-stimulated cAMP formation. Cyclic AMP adenylate cyclase activating polypeptide 1 Mus musculus
4 The VIP-2R/PACAP-R antagonist, PACAP 6-38, inhibited both VIP- and PACAP-stimulated cAMP formation. Cyclic AMP adenylate cyclase activating polypeptide 1 Mus musculus
5 The VIP-2R/PACAP-R antagonist, PACAP 6-38, inhibited both VIP- and PACAP-stimulated cAMP formation. Cyclic AMP adenylate cyclase activating polypeptide 1 Mus musculus